ArticleAmerican journal of cancer research2026

Kang Ru Plus reverses osimertinib resistance in lung adenocarcinoma via suppression of EGFR/PI3K/AKT signaling.

Thomas G Mhone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.